2. Academic Validation
  3. 4-Hydroxyderricin attenuates ischemic brain injury and neuroinflammation by upregulating haptoglobin expression in microglia

4-Hydroxyderricin attenuates ischemic brain injury and neuroinflammation by upregulating haptoglobin expression in microglia

  • Phytomedicine. 2025 Mar 15:141:156649. doi: 10.1016/j.phymed.2025.156649.
Biying Ma 1,  Wenqi Wang 2,  Zhongxia Li 3,  Chao Zhong 4,  Jing Zhou 5,  Bo Yang 6,  Liying Liu 7,  Zhanqiu Wang 8,  Xiangjiao Yi 9,  Yanrong Zheng 10,  Yiqi Wang 11
Affiliations

Affiliations

  • 1 School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, PR China; Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, PR China. Electronic address: 632598630@qq.com.
  • 2 School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, PR China; Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, PR China. Electronic address: zcmuwangwenqi@163.com.
  • 3 School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, PR China; Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, PR China. Electronic address: lizhongxia2021@163.com.
  • 4 School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, PR China; Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, PR China. Electronic address: 1203687608@qq.com.
  • 5 Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, PR China. Electronic address: zhoujing00727@163.com.
  • 6 School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, PR China. Electronic address: ybtcm@zcmu.edu.cn.
  • 7 School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, PR China. Electronic address: Liying_liu1979@126.com.
  • 8 School of Ophthalmology & Optometry, Wenzhou Medical University, Wenzhou 325035, PR China. Electronic address: 2057594970@qq.com.
  • 9 School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, PR China. Electronic address: xjyi0691@hotmail.com.
  • 10 Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, PR China. Electronic address: yanrong_zh@zju.edu.cn.
  • 11 School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, PR China; Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, PR China. Electronic address: wangyiqi@zcmu.edu.cn.
PMID: 40117946 DOI: 10.1016/j.phymed.2025.156649
Abstract

Background: Angelica keiskei (Miq.) Koidz. is a traditional plant that is widely used in Asian countries because of its tonic, diuretic, and galactagogue properties. The chalcone compound 4-hydroxyderricin (4-HD), uniquely present in A. keiskei, has demonstrated inhibitory effects on inflammation in peripheral tissues. Nonetheless, its efficacy in central neuroinflammation and ischemic brain injury remains unclear.

Purpose: This study aims to assess the ability of 4-HD to alleviate acute ischemic brain injury and the associated inflammatory response, and to elucidate the underlying mechanisms.

Methods: Mice underwent middle cerebral artery occlusion (MCAO) surgery to induce acute cerebral ischemic injury. The extent of brain injury was evaluated by TTC staining and neurological function scoring. Immunofluorescence was employed to observe glial cell activation, whereas ELISA and RT-PCR were used to quantify inflammatory cytokine expression in ischemic brain tissues. Oxygen-glucose deprivation (OGD) and lipopolysaccharide (LPS) stimulation of BV2 microglial cells were conducted in vitro to examine the direct impact of 4-HD on microglial inflammation. ELISA and RT-PCR were carried out to quantify inflammatory cytokine expression in BV2 cells. Western blotting and immunofluorescence techniques were used to detect protein expression and localization, respectively. Additionally, alterations in gene expression were measured using RNA-seq analysis profiling following 4-HD treatment of BV2 cells. A short hairpin RNA (shRNA) was used to silence the Haptoglobin (Hp) gene to elucidate the relationship between drug effects and Hp protein levels.

Results: 4-HD effectively reduced the infarct area and enhanced neurological function 24 h post-MCAO surgery by lowering inflammatory cytokine levels and inhibiting microglia activation in ischemic brain tissues. In OGD and LPS-stimulated BV2 microglia, 4-HD decreased the levels of inflammatory cytokines. Mechanistic research indicated that 4-HD enhanced Hp and reduced HMGB1 expression in BV2 cells. Moreover, the activation of the NF-κB and MAPK signaling pathways, two key pro-inflammatory pathways downstream of HMGB1, was inhibited by 4-HD treatment. In BV2 cells with Hp gene knockdown, the inhibitory effect of HMGB1 disappeared, and its anti-inflammatory effect was also significantly weakened.

Conclusion: 4-HD has the potential to mitigate brain injury and neuroinflammation resulting from MCAO-induced acute ischemic damage. This neuroprotective effect is linked to the suppression of microglial activation and the inhibition of HMGB1 pro-inflammatory signaling, facilitated by the increased expression of the Hp protein. This study revealed, for the first time, the protective effects and mechanisms of 4-HD on ischemic brain injury. Additionally, we present the Hp protein as a new target for a small-molecule compound to protect against ischemic brain injury, offering a novel strategy for developing new neuroprotective drugs.

Keywords

4-hydroxyderricin; Angelica keiskei; HMGB1; Haptoglobin; Microglia; Neuroinflammation.

Figures
Products